TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
-1.48%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$382M
AUM Growth
+$382M
(+16%)
Cap. Flow
+$58.1M
Cap. Flow
% of AUM
15.22%
Top 10 Holdings %
Top 10 Hldgs %
74.12%
Holding
33
New
8
Increased
11
Reduced
3
Closed
2
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.9M |
| 2 |
Zimmer Biomet
ZBH
|
$9.61M |
| 3 |
Integer Holdings
ITGR
|
$8.69M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
$7.76M |
| 5 |
United Therapeutics
UTHR
|
$5.98M |
Top Sells
| 1 |
Haemonetics
HAE
|
$12.1M |
| 2 |
NovoCure
NVCR
|
$9.64M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$6.37M |
| 4 |
Medtronic
MDT
|
$2.17M |
| 5 |
Quest Diagnostics
DGX
|
$1.49M |
Sector Composition
| 1 | Healthcare | 86.27% |
| 2 | Industrials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abbott
ABT
$231B
| – | – |
0
| – | – |
|
27
Amgen
AMGN
$155B
| – | – |
0
| – | – |
|
|
28
Haemonetics
HAE
$2.63B
| – | – |
-100,000
| Closed | -$12.1M |
|
29
Medpace
MEDP
$13.4B
| – | – |
0
| – | – |
|
|
30
NovoCure
NVCR
$1.38B
| – | – |
-150,000
| Closed | -$9.64M |
|
31
iShares S&P 100 ETF
OEF
$22B
| – | – |
0
| – | – |
|
32
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
33
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – |
0
| – | – |
|